Although Foxp3+ Treg populations within the inflamed intestinal mucosa of IBD patients maintain their activation markers and expressions of CTLA4 and PD-1, there are defects in their ability to migrate and repopulate the intestines (Maul et al., 2005; Goldberg et al., 2019). This evidence concerns the gene FOXP3 and inflammatory bowel disease.